Structural specificity for inhibition of [14C]-5-hydroxytryptamine uptake by cerebral slices.
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001693:Biological Transport, Active; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002247:Carbon Isotopes; D003864:Depression, Chemical; D003891:Desipramine / Q000494:pharmacology; D003984:Dibenzazepines / Q000494:pharmacology; D005260:Female; D007099:Imipramine / Q000494:pharmacology; D066298:In Vitro Techniques; D007274:Injections, Intraperitoneal; D051379:Mice; D009474:Neurons / Q000378:metabolism; D009526:Nialamide; D012110:Reserpine; D012701:Serotonin / Q000378:metabolism*; D013696:Temperature
D000928:Antidepressive Agents; D002247:Carbon Isotopes; D003984:Dibenzazepines; D012701:Serotonin; D012110:Reserpine; D007099:Imipramine; D009526:Nialamide; D003891:Desipramine